74 related articles for article (PubMed ID: 2232711)
1. Heparan sulfate proteoglycans in amyloidogenesis: an epiphenomenon, a unique factor, or the tip of a more fundamental process?
Kisilevsky R
Lab Invest; 1990 Nov; 63(5):589-91. PubMed ID: 2232711
[No Abstract] [Full Text] [Related]
2. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid.
Lyon AW; Narindrasorasak S; Young ID; Anastassiades T; Couchman JR; McCarthy KJ; Kisilevsky R
Lab Invest; 1991 Jun; 64(6):785-90. PubMed ID: 2046330
[TBL] [Abstract][Full Text] [Related]
3. The glomerular basement membrane charge-selectivity barrier: an oversimplified concept?
Goode NP; Shires M; Davison AM
Nephrol Dial Transplant; 1996 Sep; 11(9):1714-6. PubMed ID: 8918607
[No Abstract] [Full Text] [Related]
4. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor.
Vigny M; Ollier-Hartmann MP; Lavigne M; Fayein N; Jeanny JC; Laurent M; Courtois Y
J Cell Physiol; 1988 Nov; 137(2):321-8. PubMed ID: 2973466
[TBL] [Abstract][Full Text] [Related]
5. [Connective matrix and localization of a biological signal: demonstration of a matrix receptor for interferon-gamma in basement membranes].
Lortat-Jacob H; Kleinman H; Grimaud JA
C R Acad Sci III; 1990; 311(4):143-7. PubMed ID: 2119865
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific remodeling of the mammary gland basement membrane during lactogenic development.
Beck JC; Lekutis C; Couchman J; Parry G
Biochem Biophys Res Commun; 1993 Jan; 190(2):616-23. PubMed ID: 8427603
[TBL] [Abstract][Full Text] [Related]
7. [Immunoelectron microscopic observations on proteoheparan sulfate in normal human lung].
Takusagawa K; Asoo N; Hasuike M; Sato T; Nagai H; Motomiya M; Konno K
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jul; 25(7):738-43. PubMed ID: 2961905
[No Abstract] [Full Text] [Related]
8. [Role of heparan sulfate proteoglycan for control of cell growth].
Ishihara M; Mamiya G
Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):853-62. PubMed ID: 2678273
[No Abstract] [Full Text] [Related]
9. Differences in the solubility and susceptibility to proteolytic degradation of basement-membrane components in adult and embryonic mouse tissues.
Dziadek M; Mitrangas K
Am J Anat; 1989 Apr; 184(4):298-310. PubMed ID: 2526998
[TBL] [Abstract][Full Text] [Related]
10. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
Templeton DM
Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: the proteoglycans hypothesis.
Celesia GG
Semin Thromb Hemost; 1991; 17 Suppl 2():158-60. PubMed ID: 1948087
[No Abstract] [Full Text] [Related]
12. Heparan sulfate proteoglycans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin.
Vallen EA; Eldridge KA; Culp LA
J Cell Physiol; 1988 May; 135(2):200-12. PubMed ID: 2967301
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
14. Cell surface heparan sulfate proteoglycan and the neoplastic phenotype.
Iozzo RV
J Cell Biochem; 1988 May; 37(1):61-78. PubMed ID: 2968986
[TBL] [Abstract][Full Text] [Related]
15. Macromolecular organization and functional architecture of basement membranes.
Garbisa S; Negro A
Appl Pathol; 1984; 2(4):217-22. PubMed ID: 6545135
[TBL] [Abstract][Full Text] [Related]
16. [Intermediate receptors].
Inki P; Jalkanen M
Duodecim; 1988; 104(20):1597-604. PubMed ID: 2973408
[No Abstract] [Full Text] [Related]
17. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.
Narindrasorasak S; Altman RA; Gonzalez-DeWhitt P; Greenberg BD; Kisilevsky R
Lab Invest; 1995 Mar; 72(3):272-82. PubMed ID: 7898047
[TBL] [Abstract][Full Text] [Related]
18. Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds.
Leveugle B; Scanameo A; Ding W; Fillit H
Neuroreport; 1994 Jun; 5(11):1389-92. PubMed ID: 7522615
[TBL] [Abstract][Full Text] [Related]
19. Characterization and localization of basement membrane-associated heparan sulfate proteoglycan in human tissues.
Schleicher ED; Wagner EM; Olgemöller B; Nerlich AG; Gerbitz KD
Lab Invest; 1989 Sep; 61(3):323-32. PubMed ID: 2475665
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the axolemmal mitogen for cultured Schwann cells is a positively charged, heparan sulfate proteoglycan-bound, heparin-displaceable molecule.
DeCoster MA; DeVries GH
J Neurosci Res; 1989 Mar; 22(3):283-8. PubMed ID: 2523488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
